ClearBridge Investments
TEVA icon

ClearBridge Investments’s Teva Pharmaceuticals TEVA Stock Holding History

ClearBridge Investments’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-200
Closed -$2K – 970
2020
Q2 		$2K Hold
200
– – ﹤0.01% 943
2020
Q1 		$2K Hold
200
– – ﹤0.01% 1018
2019
Q4 		$2K Hold
200
– – ﹤0.01% 1068
2019
Q3 		$1K Hold
200
– – ﹤0.01% 1102
2019
Q2 		$2K Sell
200
-1,178,684
-100% -$14.2M ﹤0.01% 1067
2019
Q1 		$18.5M Sell
1,178,884
-28,084
-2% -$495K 0.02% 435
2018
Q4 		$18.6M Buy
1,206,968
+51,853
+4% +$1.06M 0.02% 424
2018
Q3 		$24.9M Buy
1,155,115
+31,419
+3% +$729K 0.02% 417
2018
Q2 		$27.3M Buy
1,123,696
+37,226
+3% +$759K 0.02% 387
2018
Q1 		$18.6M Buy
1,086,470
+38,749
+4% +$757K 0.02% 411
2017
Q4 		$19.9M Buy
1,047,721
+332,430
+46% +$5M 0.02% 417
2017
Q3 		$12.6M Sell
715,291
-1,417,185
-66% -$31.9M 0.01% 461
2017
Q2 		$70.8M Sell
2,132,476
-8,040
-0.4% -$249K 0.07% 247
2017
Q1 		$68.7M Sell
2,140,516
-13,383
-0.6% -$457K 0.07% 257
2016
Q4 		$78.1M Sell
2,153,899
-196,563
-8% -$7.85M 0.09% 202
2016
Q3 		$108M Sell
2,350,462
-775,116
-25% -$40.4M 0.12% 162
2016
Q2 		$157M Sell
3,125,578
-475,748
-13% -$25.3M 0.19% 129
2016
Q1 		$193M Sell
3,601,326
-84,185
-2% -$4.94M 0.23% 110
2015
Q4 		$242M Buy
3,685,511
+51,708
+1% +$3.2M 0.28% 96
2015
Q3 		$205M Sell
3,633,803
-124,487
-3% -$8.07M 0.25% 113
2015
Q2 		$222M Buy
3,758,290
+216,273
+6% +$13.3M 0.23% 116
2015
Q1 		$221M Sell
3,542,017
-71,082
-2% -$4.13M 0.23% 123
2014
Q4 		$208M Buy
3,613,099
+101,914
+3% +$5.68M 0.22% 124
2014
Q3 		$189M Sell
3,511,185
-26,531
-0.7% -$1.41M 0.21% 128
2014
Q2 		$185M Sell
3,537,716
-39,965
-1% -$2.04M 0.21% 125
2014
Q1 		$189M Sell
3,577,681
-9,249
-0.3% -$427K 0.22% 122
2013
Q4 		$144M Sell
3,586,930
-38,836
-1% -$1.53M 0.18% 142
2013
Q3 		$137M Buy
3,625,766
+48,245
+1% +$1.88M 0.19% 141
2013
Q2 		$140M Buy
+3,577,521
New +$139M 0.21% 135

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

ClearBridge Investments's TEVA Position: Q3 2020 in Review

ClearBridge Investments sold out of Teva Pharmaceuticals (TEVA) in Q3 2020, closing a stake of 200 shares — an estimated $2K sold.

ClearBridge Investments first reported a position in TEVA in Q2 2013 and held it in 29 quarters. The position peaked at $242M in Q4 2015. 444 funds tracked by Wall St. Rank hold TEVA as of Q3 2020.

  • ClearBridge Investments reported no remaining Teva Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • ClearBridge Investments sold 200 Teva Pharmaceuticals shares in Q3 2020, an estimated $2K.
  • ClearBridge Investments first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 29 quarters.
  • ClearBridge Investments's Teva Pharmaceuticals position peaked at $242M in Q4 2015.
  • 444 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2020.

Based on ClearBridge Investments's 13F filing for Q3 2020, filed 12 Nov 2020.